Entries for the Scrip Awards are now open. Now in their 20th year, the Awards seek to reward the outstanding achievements of the pharmaceutical, biotech and allied industries in improving human health.
Entries are now open for the 20th Annual Scrip Awards.
Firmly established as best-in-class for pharma and biotech, the Scrip Awards will be held on Wednesday, 4 December 2024 at...
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Lynkuet will compete with Astellas's Veozah/Veoza
The list of fastest growing small-cap companies was dominated by Chinese companies in early 2025, underscoring their growing contribution to the global biopharma ecosystem.
Soleno Therapeutics will raise about $200m gross proceeds from an offering of 2.35m of its common stock to fund the commercialization of Vykat XR, which became the first drug for Prader-Willi syndrome to gain US approval on March 26.
Glenmark’s managing director talks about IGI’s billion dollar-plus deal with AbbVie, ISB-2001’s striking data, the BEAT platform, other "exciting" pipeline assets and the "blood, sweat and tears" to get to this stage.
Four Chinese companies have won approvals in China, the first anywhere, for novel drugs for diffuse large B-cell lymphoma, certain types of non-small cell lung cancer and influenza A.
IGI CEO Cyril Konto said in an interview that his company picked AbbVie for its agility, drug development acumen and expertise in areas like intellectual property and legal affairs.
CEO Rob Davis said the company is in pursuit of more deals as it looks to close the revenue gap looming from the loss of Keytruda in 2028.
